Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.02M | $170M | -99.40% |
Operating Income | $-291.85M | $-159.71M | -82.74% |
Net Income | $-126.41M | $-77.74M | -62.60% |
EPS (Basic) | $-2.92 | $-1.66 | -75.90% |
EPS (Diluted) | $-2.92 | $-1.66 | -75.90% |
R&D Expense | $156.34M | $201.49M | -22.41% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.34B | $2.2B | +6.50% |
Current Assets | $2.01B | $1.86B | +8.11% |
Total Liabilities | $358.9M | $380.99M | -5.80% |
Current Liabilities | $127.82M | $132.84M | -3.77% |
Stockholders' Equity | $1.98B | $1.82B | +9.08% |
Cash & Equivalents | $484.47M | $444.8M | +8.92% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $14.17M | $-124.45M | +111.39% |
Investing Cash Flow | $-224.71M | $334.75M | -167.13% |
Financing Cash Flow | $305.47M | $22.17M | +1277.91% |
D&A | $9.68M | $10.01M | -3.34% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -28584.5% | -93.9% | -28490.58% |
Net Margin | -12380.8% | — | — |
ROE | -6.4% | — | — |
ROA | -5.4% | — | — |
Current Ratio | $15.728 | — | — |
Debt to Equity | $0.181 | — | — |
Other companies in Biotechnology